Arnogene: A Phosphocalcic Study in Dialysis

Genetic Determinants of Phosphocalcic Metabolism in Hemodialysis Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00858260

Acronym

ARNOGENE

Enrollment

1200

Registered

2009-03-09

Start date

2008-11-30

Completion date

2009-02-28

Last updated

2009-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis

Keywords

Klotho, calcium, phosphate, parathormone, survival, dialysis, Adult patients undergoing maintenance dialysis since at leat three months

Brief summary

Searching for high morbi-mortality risk Klotho variants in dialysis patients

Interventions

GENETICblood sample

Searching for Klotho variants in DNA

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Every adult \> 18 years old and treated by dialysis in centers located in the Rhone Alpes area in France.

Design outcomes

Primary

Measure	Time frame
Assessing morbi-mortality based on Klotho variants	—

Secondary

Measure	Time frame
Survival and serum phosphocalcic parameters	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026